FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,872 letters match. Newest first.

  1. Root Bioscience Brands, LLC dba Naternal

    FDA warned Naternal that its CBD oils, gummies, and pet hemp oil are unapproved drugs due to drug claims.

    High risk
  2. Zydus Lifesciences Limited

    FDA warned Zydus Lifesciences over cross-contamination and glass particles in its injectable drugs, leading to recalls.

    High risk
  3. Orean Personal Care Ltd.

    FDA warned Orean Personal Care Ltd. that repeat manufacturing failures make its OTC drugs adulterated.

    High risk
  4. Optikem International, Inc.

    FDA cited Optikem International of Denver for unvalidated sterilization and unapproved formulation changes to its Sereine contact lens solutions.

    High risk
  5. Regenerative Processing Plant, LLC

    FDA warns Regenerative Processing Plant over unapproved, misbranded Regener-Eyes eye drops and serious sterile manufacturing violations.

    High risk
  6. 100Misterios, LDA

    Portuguese canner 100Misterios' seafood safety plans and sardine canning process controls fall short, FDA says

    High risk
  7. SoloVital

    FDA says SoloVital's Umary supplement is an unapproved, misbranded drug containing hidden diclofenac and omeprazole.

    High risk
  8. Julio R. Flamini, M.D./Clinical Integrative Research Center of Atlanta

    FDA warns an Atlanta clinical investigator after a 15-year-old trial subject was given about 10 times the protocol dose.

    High risk
  9. Kaylaan LLC

    FDA warns Kaylaan LLC that its fluoride toothpaste tablets were made without release testing, raw material identity testing, and adequate CGMP controls.

    High risk
  10. Graceleigh, Inc. dba Sammy’s Milk

    FDA warned Sammy's Milk that it markets goat milk toddler formula as infant formula without required notice and falsely claimed Cronobacter testing.

    High risk
  11. Dasada Group LLC

    FDA warned Dasada Group it lacked required supplier food-safety verification for imported bananas, habanero peppers, and plantains, and cited registration.

    Medium
  12. Shenzhen Moyeah Intelligent Life Technology Co.

    Shenzhen Moyeah sold ozone and UV CPAP cleaner and sanitizer devices in the U.S. without FDA clearance or approval, FDA says.

    High risk
  13. LEEL Tech

    FDA warns LEEL Tech that its CLYN, LEEL, and SOLID CPAP cleaners/sanitizers are sold in the U.S. without required clearance or approval.

    Medium
  14. Adventure Innovations LLC

    FDA says Adventure Innovations sold Sani Bot D3, a CPAP cleaner, without device clearance or approval.

    Medium
  15. Natures Pillows, Inc. and Top Dog Direct, LLC

    FDA warns Natures Pillows and Top Dog Direct that Clean Zone CPAP Sanitizer is an unapproved, misbranded device.

    High risk
  16. AnuMed International, LLC

    FDA warned AnuMed International about unapproved drugs, misleading FDA claims, and manufacturing quality failures.

    High risk
  17. HH Fresh Trading Corp

    FDA warned HH Fresh Trading Corp it lacked a foreign supplier verification program for imported produce after Listeria was found in enoki mushrooms.

    High risk
  18. J. Moniz Company Inc.

    J. Moniz Company, a Massachusetts seafood importer, failed to verify that Portuguese bonito and sardines were processed under seafood HACCP rules.

    High risk
  19. 1 Stop Chicken Health Shop

    FDA warns 1 Stop Chicken Health Shop over selling unapproved animal drugs, including toltrazuril and enrofloxacin, for poultry and other birds.

    High risk
  20. Minland of Texas, Inc.

    FDA warned Minland of Texas that it lacked a required Foreign Supplier Verification Program for imported peanut gluten, soy sauce, and rice vinegar.

    Medium
  21. EyePoint Pharmaceuticals, Inc.

    FDA cited EyePoint Pharmaceuticals in Watertown, MA for manufacturing-quality violations affecting its YUTIQ eye implant, including inadequate investigations and process controls.

    High risk
  22. Media Networks Sydney Pty Limited

    Media Networks Sydney failed to properly list Mylanta 2go Antacid and Microlax Enema with FDA, making them misbranded.

    Low
  23. Eugia Pharma Specialities Limited

    FDA cited Eugia Pharma Specialities for CGMP violations at its India sterile injectable plant, including falsified records and contamination risks.

    High risk
  24. Intercos Europe S.p.A

    FDA warned Intercos Europe S.p.A over current good manufacturing practice violations in OTC sunscreen drugs, including missing glycerin DEG/EG testing and poor investigations.

    High risk
  25. Manabi Export Panama S.A.

    FDA cited Panama seafood processor Manabi Export for missing HACCP (food-safety plan) controls on ready-to-eat cooked clam meat in reduced-oxygen packaging.

    High risk
  26. P&L Bean Sprout Farm

    FDA says P&L Bean Sprout Farm's ready-to-eat mung and soybean sprouts were held under insanitary conditions, including rodent feces and falling sludge.

    High risk
  27. AUSTROFOOD S.A.S.

    Austrofood's apple cinnamon puree pouches were adulterated with extremely high lead from cinnamon; hazard controls failed.

    High risk
  28. LS Promotions Inc.

    LS Promotions Inc. failed to adequately test and validate its OTC sunscreens, lip balm and hand sanitizer, making them adulterated drugs.

    High risk
  29. Txsyn Int. LLC

    FDA says Txsyn Int. repackaged dietary supplements without required manufacturing procedures and quality approval.

    Medium
  30. Globus Medical, Inc.

    FDA warns Globus Medical over Excelsius GPS robot-related misplaced screw complaints and late or missing device reports.

    High risk
  31. Nowrez & Ismail Shukri Company

    FDA warns Jordanian OTC drug maker Nowrez & Ismail Shukri over CGMP violations and import alert.

    High risk
  32. Central Admixture Pharmacy Services, Inc.

    FDA warns Central Admixture Pharmacy Services over sterile compounded drugs, contamination risks, and quality failures at its San Diego site.

    High risk
  33. Baylab USA, LLC

    Baylab USA sold unapproved Level 1 masks, KN95 respirators and unclear colors and kids' versions of its Level 3 mask, FDA says.

    High risk
  34. Konrad Rejdak, M.D., Ph.D.

    FDA warns Dr. Konrad Rejdak over clinical trial data integrity failures in a CIDP immune globulin study.

    Medium
  35. Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.

    FDA warned Guangzhou Baiyunshan Jingxiutang Pharmaceutical over current good manufacturing practice violations in over-the-counter drug manufacturing, including inadequate specs and microbial testing.

    High risk
  36. Omega Tech Labs LLC

    Omega Tech Labs in Boise, Idaho, released microbially contaminated combination drug-device product and failed manufacturing rules.

    High risk
  37. Velocity Pharma LLC

    Velocity Pharma distributed eye drop drugs made by contract manufacturers with serious manufacturing and sanitation violations.

    High risk
  38. Walmart, Inc.

    FDA warned Walmart over selling an unapproved 90% lactic acid chemical peel drug that can cause burns.

    High risk
  39. ISIS.GOLD

    ISIS.GOLD sells TCA 100% and Whitening SA chemical peels as unapproved new drugs without FDA-approved applications.

    High risk
  40. Skin Beauty Solutions

    FDA warns Skin Beauty Solutions that its chemical peel products are unapproved new drugs sold with acne and scar treatment claims.

    High risk
  41. Matte Beauty

    FDA warned Matte Beauty that its chemical peel drugs are unapproved and sold with treatment claims.

    High risk
  42. Corporacion Avicola Morovis Inc

    FDA warns Corporacion Avicola Morovis over Salmonella prevention failures at its Puerto Rico shell egg farm.

    High risk
  43. AMCO International Manufacturing & Design, Inc.

    AMCO International made and sold AED replacement batteries without required FDA approval, FDA says.

    High risk
  44. V10Suppliers.com

    FDA warned UK website V10Suppliers.com for selling unapproved, misbranded opioid drugs to U.S. consumers.

    High risk
  45. Criticare Technologies, Inc.

    FDA warns Criticare Technologies over patient monitors after finding unresolved CAPAs, weak design controls and supplier checks at its Warwick, Rhode Island plant.

    High risk
  46. Brassica Pharma Pvt. Ltd.

    FDA warns Brassica Pharma over fabricated sterility and environmental data and poor aseptic controls for sterile drugs.

    High risk
  47. Formulation Technology, Inc.

    FDA warns Formulation Technology over unapproved migraine supplement claims and manufacturing/labeling violations.

    High risk
  48. Greenfruit Avocados, LLC

    FDA warns Greenfruit Avocados after foreign supplier verification inspection found it did not verify avocado growers.

    Medium
  49. Genuine Virgin Aloe Corp dba Triderma

    FDA warned Triderma, an Anaheim OTC skin cream maker, of CGMP violations after a January 2024 inspection.

    High risk
  50. Key Foods Co. dba Key Food Services

    FDA warned Key Foods Co. dba Key Food Services that it lacked required Foreign Supplier Verification Program plans for several imported foods.

    Medium